WO1999039001A3 - Nucleic acid analysis method - Google Patents

Nucleic acid analysis method Download PDF

Info

Publication number
WO1999039001A3
WO1999039001A3 PCT/EP1999/000918 EP9900918W WO9939001A3 WO 1999039001 A3 WO1999039001 A3 WO 1999039001A3 EP 9900918 W EP9900918 W EP 9900918W WO 9939001 A3 WO9939001 A3 WO 9939001A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
array
analysis method
acid analysis
probes
Prior art date
Application number
PCT/EP1999/000918
Other languages
French (fr)
Other versions
WO1999039001A2 (en
Inventor
Per Johan Ulfendahl
Original Assignee
Amersham Pharm Biotech Ab
Per Johan Ulfendahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Pharm Biotech Ab, Per Johan Ulfendahl filed Critical Amersham Pharm Biotech Ab
Priority to JP2000529458A priority Critical patent/JP2002501760A/en
Priority to US09/601,258 priority patent/US6280954B1/en
Priority to EP99911663A priority patent/EP1051523A2/en
Priority to AU30276/99A priority patent/AU3027699A/en
Publication of WO1999039001A2 publication Critical patent/WO1999039001A2/en
Publication of WO1999039001A3 publication Critical patent/WO1999039001A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Abstract

A nucleic acid analysis method comprises: using a primer to amplify the nucleic acid; providing an array of probes, each probe comprising a sequence identical to the primer and an adjacent sequence; applying fragements of the amplifier nucleic acid under hybridisation conditions to the array; effecting enzymatic chain extension of any probe where the adjacent sequence matches that of a hybridised fragment of the amplified nucleic acid; and observing the location of probes of the array while chain extension has taken place.
PCT/EP1999/000918 1998-02-02 1999-02-02 Nucleic acid analysis method WO1999039001A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000529458A JP2002501760A (en) 1998-02-02 1999-02-02 Nucleic acid analysis method
US09/601,258 US6280954B1 (en) 1998-02-02 1999-02-02 Arrayed primer extension technique for nucleic acid analysis
EP99911663A EP1051523A2 (en) 1998-02-02 1999-02-02 Nucleic acid analysis method
AU30276/99A AU3027699A (en) 1998-02-02 1999-02-02 Nucleic acid analysis method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98300741 1998-02-02
EP98300741.0 1998-02-02

Publications (2)

Publication Number Publication Date
WO1999039001A2 WO1999039001A2 (en) 1999-08-05
WO1999039001A3 true WO1999039001A3 (en) 1999-10-07

Family

ID=8234645

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/000918 WO1999039001A2 (en) 1998-02-02 1999-02-02 Nucleic acid analysis method

Country Status (5)

Country Link
US (1) US6280954B1 (en)
EP (1) EP1051523A2 (en)
JP (1) JP2002501760A (en)
AU (1) AU3027699A (en)
WO (1) WO1999039001A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883424B2 (en) 1999-05-21 2014-11-11 Illumina, Inc. Use of microfluidic systems in the detection of target analytes using microsphere arrays
US8906626B2 (en) 2000-02-07 2014-12-09 Illumina, Inc. Multiplex nucleic acid reactions
US9012144B2 (en) 2003-11-12 2015-04-21 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US9279148B2 (en) 1999-04-20 2016-03-08 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US9399795B2 (en) 1998-06-24 2016-07-26 Illumina, Inc. Multiplex decoding of array sensors with microspheres
US9410146B2 (en) 2009-09-14 2016-08-09 Qiagen Gaithersburg Inc. Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media
US9416411B2 (en) 1999-08-18 2016-08-16 Illumina, Inc. Compositions and methods for preparing oligonucleotide solutions
US9422593B2 (en) 2010-05-19 2016-08-23 Qiagen Gaithresburg, Inc Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
US9540689B2 (en) 1998-05-01 2017-01-10 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1032705B1 (en) 1997-10-30 2011-12-14 Cold Spring Harbor Laboratory Probe arrays and methods of using probe arrays for distinguishing dna
US7399589B2 (en) 1998-02-06 2008-07-15 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US6686151B1 (en) * 1998-02-06 2004-02-03 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6544732B1 (en) 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US6448010B1 (en) 1999-10-06 2002-09-10 Amersham Pharmacia Biotech, Inc. Method for detecting mutations using arrayed primer extension
WO2001036679A2 (en) * 1999-11-15 2001-05-25 Hartwell John G METHODS FOR GENERATING SINGLE STRANDED cDNA FRAGMENTS
WO2001038580A2 (en) * 1999-11-26 2001-05-31 Curagen Corporation Nucleic acid probe arrays
WO2001057268A2 (en) 2000-02-07 2001-08-09 Illumina, Inc. Nucleic acid detection methods using universal priming
EP1967595A3 (en) 2000-02-16 2008-12-03 Illumina, Inc. Parallel genotyping of multiple patient samples
US6376191B1 (en) * 2000-03-22 2002-04-23 Mergen, Ltd. Microarray-based analysis of polynucleotide sequence variations
AU2001257448A1 (en) * 2000-05-01 2001-11-12 Cold Spring Harbor Laboratory Use of representations of dna for genetic analysis
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US7439016B1 (en) 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
CH699253B1 (en) * 2000-09-18 2010-02-15 Eidgenoessische Forschungsanst A method of characterizing and / or identification of genomes.
US20020155476A1 (en) 2000-10-20 2002-10-24 Nader Pourmand Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample
EP1207209A3 (en) * 2000-11-09 2002-09-11 Agilent Technologies, Inc. (a Delaware corporation) Methods using arrays for detection of single nucleotide polymorphisms
WO2002059357A2 (en) * 2001-01-24 2002-08-01 Genomic Expression Aps Assay and kit for analyzing gene expression
US20040038206A1 (en) * 2001-03-14 2004-02-26 Jia Zhang Method for high throughput assay of genetic analysis
US20030017567A1 (en) * 2001-04-24 2003-01-23 3M Innovative Properties Company Biological sample processing methods and compositions that include surfactants
US6617136B2 (en) * 2001-04-24 2003-09-09 3M Innovative Properties Company Biological sample processing methods and compositions that include surfactants
US20030036073A1 (en) * 2001-06-07 2003-02-20 Saba James Anthony Matrix Sequencing: a novel method of polynucleotide analysis utilizing probes containing universal nucleotides
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US20040161741A1 (en) * 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9777312B2 (en) * 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20030087298A1 (en) * 2001-11-02 2003-05-08 Roland Green Detection of hybridization on oligonucleotide microarray through covalently labeling microarray probe
US20030170637A1 (en) * 2002-03-06 2003-09-11 Pirrung Michael C. Method of analyzing mRNA splice variants
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
US20030186252A1 (en) * 2002-04-01 2003-10-02 Ilsley Diane D. Array based hybridization assays employing enzymatically generated labeled target nucleic acids and compositions for practicing the same
WO2004065000A1 (en) 2003-01-21 2004-08-05 Illumina Inc. Chemical reaction monitor
RU2390561C2 (en) 2003-05-23 2010-05-27 Колд Спринг Харбор Лэборетери Virtual sets of fragments of nucleotide sequences
US20040259100A1 (en) * 2003-06-20 2004-12-23 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
EP1636337A4 (en) 2003-06-20 2007-07-04 Illumina Inc Methods and compositions for whole genome amplification and genotyping
US20050181394A1 (en) * 2003-06-20 2005-08-18 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
US20050048544A1 (en) * 2003-07-10 2005-03-03 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining whether a subject carries a cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation
US20050153320A1 (en) * 2003-11-06 2005-07-14 Herron James N. Single base extension
WO2005080605A2 (en) 2004-02-19 2005-09-01 Helicos Biosciences Corporation Methods and kits for analyzing polynucleotide sequences
WO2007024295A2 (en) * 2005-05-02 2007-03-01 The Board Of Trustees Of The Leland Stanford Junior University Capture and random amplification protocol for identification and monitoring of microbial diversity
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US20070196832A1 (en) * 2006-02-22 2007-08-23 Efcavitch J William Methods for mutation detection
WO2010062556A1 (en) 2008-10-27 2010-06-03 Qiagen Gaithersburg Inc. Fast results hybrid capture assay and system
ES2644516T3 (en) * 2009-01-28 2017-11-29 Qiagen Gaithersburg, Inc. Method and test for sample preparation of large sequence specific volume
WO2010107825A2 (en) 2009-03-16 2010-09-23 Pangu Biopharma Limited Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
CA2757289A1 (en) 2009-03-31 2010-10-21 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
CN102414327B (en) 2009-05-01 2015-04-08 奇亚根盖瑟斯堡股份有限公司 A non-target amplification method for detection of RNA splice-forms in a sample
JP5765841B2 (en) * 2009-05-27 2015-08-19 富士フイルム株式会社 Nucleic acid microarray quality inspection method
WO2011094528A2 (en) 2010-01-29 2011-08-04 Qiagen Gaithersburg, Inc. Method of determining and confirming the presence of an hpv in a sample
JP6103941B2 (en) 2010-01-29 2017-03-29 キアジェン ゲイサーズバーグ インコーポレイテッド Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
EP2563380B1 (en) 2010-04-26 2018-05-30 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
AU2011248614B2 (en) 2010-04-27 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
US8993723B2 (en) 2010-04-28 2015-03-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
EP2563383B1 (en) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
WO2011135459A2 (en) 2010-04-29 2011-11-03 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy
CA2797374C (en) 2010-04-29 2021-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
CN103140233B (en) 2010-05-03 2017-04-05 Atyr 医药公司 Treatment, diagnosis and the discovery of antibody compositions related to the protein fragments of methionyl-tRNA synthetase
ES2623805T3 (en) 2010-05-03 2017-07-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic and antibody compositions related to phenylalanyl-alpha-tRNA synthetase protein fragments
WO2011139986A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
JP6008844B2 (en) 2010-05-04 2016-10-19 エータイアー ファーマ, インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of the p38 MULTI-tRNA synthetase complex
AU2011252990B2 (en) 2010-05-14 2017-04-20 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
CA2799480C (en) 2010-05-17 2020-12-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
WO2011153277A2 (en) 2010-06-01 2011-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
WO2012021247A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
AU2011293294B2 (en) 2010-08-25 2016-03-24 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
US9885092B2 (en) 2011-02-24 2018-02-06 Qiagen Gaithersburg Inc. Materials and methods for detection of HPV nucleic acids
CA2836836A1 (en) 2011-06-01 2012-12-06 Medical Prognosis Institute A/S Methods and devices for prognosis of cancer relapse
EP2814514B1 (en) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
WO2014085434A1 (en) 2012-11-27 2014-06-05 Pontificia Universidad Catolica De Chile Compositions and methods for diagnosing thyroid tumors
GB201301857D0 (en) * 2013-02-01 2013-03-20 Selvi Ozan Method
WO2014195032A1 (en) 2013-06-07 2014-12-11 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
CA2954764A1 (en) 2014-07-15 2016-01-21 Ontario Institute For Cancer Research Methods and devices for predicting anthracycline treatment efficacy
US9932631B1 (en) 2017-09-11 2018-04-03 Omniome, Inc. Genotyping by polymerase binding
EP3571313B1 (en) 2017-01-20 2020-12-23 Omniome, Inc. Allele-specific capture of nucleic acids
US11753486B2 (en) 2017-12-28 2023-09-12 Borealis Ag Catalyst and preparation thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005060A2 (en) * 1989-09-29 1991-04-18 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
WO1991014001A2 (en) * 1990-03-14 1991-09-19 E.I. Du Pont De Nemours And Company A process for distinguishing nucleic acids on the basis of nucleotide differences
EP0534858A1 (en) * 1991-09-24 1993-03-31 Keygene N.V. Selective restriction fragment amplification : a general method for DNA fingerprinting
WO1993017126A1 (en) * 1992-02-19 1993-09-02 The Public Health Research Institute Of The City Of New York, Inc. Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
EP0630972A2 (en) * 1993-06-25 1994-12-28 Hitachi, Ltd. DNA analyzing method
EP0649852A1 (en) * 1993-10-26 1995-04-26 Hitachi, Ltd. Fractionation method for nucleotide fragments
EP0701001A2 (en) * 1994-09-07 1996-03-13 Hitachi, Ltd. DNA separating, fractionating and analyzing method and system therefor
WO1996041893A1 (en) * 1995-06-09 1996-12-27 The University Of Tennessee Research Corporation Methods for the generation of sequence signatures from nucleic acids
WO1997022720A1 (en) * 1995-12-21 1997-06-26 Kenneth Loren Beattie Arbitrary sequence oligonucleotide fingerprinting

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004744A (en) * 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US5981176A (en) * 1992-06-17 1999-11-09 City Of Hope Method of detecting and discriminating between nucleic acid sequences
US5503980A (en) * 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005060A2 (en) * 1989-09-29 1991-04-18 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
WO1991014001A2 (en) * 1990-03-14 1991-09-19 E.I. Du Pont De Nemours And Company A process for distinguishing nucleic acids on the basis of nucleotide differences
EP0534858A1 (en) * 1991-09-24 1993-03-31 Keygene N.V. Selective restriction fragment amplification : a general method for DNA fingerprinting
WO1993017126A1 (en) * 1992-02-19 1993-09-02 The Public Health Research Institute Of The City Of New York, Inc. Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
EP0630972A2 (en) * 1993-06-25 1994-12-28 Hitachi, Ltd. DNA analyzing method
EP0649852A1 (en) * 1993-10-26 1995-04-26 Hitachi, Ltd. Fractionation method for nucleotide fragments
EP0701001A2 (en) * 1994-09-07 1996-03-13 Hitachi, Ltd. DNA separating, fractionating and analyzing method and system therefor
WO1996041893A1 (en) * 1995-06-09 1996-12-27 The University Of Tennessee Research Corporation Methods for the generation of sequence signatures from nucleic acids
WO1997022720A1 (en) * 1995-12-21 1997-06-26 Kenneth Loren Beattie Arbitrary sequence oligonucleotide fingerprinting

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9540689B2 (en) 1998-05-01 2017-01-10 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9399795B2 (en) 1998-06-24 2016-07-26 Illumina, Inc. Multiplex decoding of array sensors with microspheres
US9279148B2 (en) 1999-04-20 2016-03-08 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US9441267B2 (en) 1999-04-20 2016-09-13 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US8883424B2 (en) 1999-05-21 2014-11-11 Illumina, Inc. Use of microfluidic systems in the detection of target analytes using microsphere arrays
US9289766B2 (en) 1999-05-21 2016-03-22 Illumina, Inc. Use of microfluidic systems in the detection of target analytes using microsphere arrays
US9416411B2 (en) 1999-08-18 2016-08-16 Illumina, Inc. Compositions and methods for preparing oligonucleotide solutions
US8906626B2 (en) 2000-02-07 2014-12-09 Illumina, Inc. Multiplex nucleic acid reactions
US9012144B2 (en) 2003-11-12 2015-04-21 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US9410146B2 (en) 2009-09-14 2016-08-09 Qiagen Gaithersburg Inc. Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media
US9422593B2 (en) 2010-05-19 2016-08-23 Qiagen Gaithresburg, Inc Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids

Also Published As

Publication number Publication date
EP1051523A2 (en) 2000-11-15
JP2002501760A (en) 2002-01-22
AU3027699A (en) 1999-08-16
US6280954B1 (en) 2001-08-28
WO1999039001A2 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
WO1999039001A3 (en) Nucleic acid analysis method
NZ336769A (en) Method of determining hybridization of a probe to a target nucleic acid
CA2294470A1 (en) Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
EP1196623B8 (en) Method for detecting single nucleotide polymorphisms
WO2001061033A3 (en) Multiplex ligatable probe amplification
EP1308523A3 (en) Detecting DNA sequence variations
CA2212185A1 (en) Methods for the isothermal amplification of nucleic acid molecules
WO2003040395A3 (en) Universal nucleotides for nucleic acid analysis
DE69801571D1 (en) HYBRIDIZATION PROCEDURE IN WHICH EXCESS PROBES ARE DEGRADED
AU7222698A (en) Method of preparing a standard diagnostic gene transcript pattern
AU6345700A (en) Derivative nucleic acids and uses thereof
EP1063286A4 (en) Substrates for immobilizing and amplifying dna, dna-immobilized chips having dna immobilized on the substrates, and method for amplifying dna
CA2230967A1 (en) Improved nucleic acid assays
WO2002000842A3 (en) Methods for isolating centromere dna
WO1996012040A3 (en) Compositions and methods for the detection of chlamydia trachomatis
WO2003054209A3 (en) A method of reducing non-specific amplification in pcr
WO2000047764A3 (en) Test kit and method for quantitatively detecting genetically modified dna in foodstuff by means of fluorescence-coupled pcr
WO2003020878A3 (en) Amplification and detection reagents for hiv-1
AU2623197A (en) Method for the detection of telomerase activity
WO2000061800A8 (en) Method for the analysis of aflp® reaction mixtures using primer extension techniques
WO2000060114A3 (en) Polynucleotide sequencing using a helicase
WO2000075363A3 (en) Enzymatic measurement of mycophenolic acid
WO2004050911A3 (en) Method for lowering both sequence variations and increase of base lines effects in diagnostic hybridisation assay, assay for performing such a method and probe for use in the assay
WO1997046709A3 (en) NUCLEIC ACID PRIMERS AND PROBES FOR DETECTING $i(CHLAMYDIA PNEUMONIAE)
EP0795612A3 (en) Amplifying and detecting target nucleic acids using a post amplification incubation step

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999911663

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09601258

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999911663

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1999911663

Country of ref document: EP